Association between dementia and infectious disease: Evidence from a case-control study

Alzheimer Disease and Associated Disorders

Volumn 19, Issue 2, 2005, Pages 91-94

  Dunn, Nicholas ^a,b   Mullee, Mark ^a   Perry, Hugh ^a   Holmes, Clive ^a  

^a UNIVERSITY OF SOUTHAMPTON   (United Kingdom)

^b University of Southampton ^*  (United Kingdom)

Author keywords

Dementia; Infection; Inflammation

Indexed keywords

ADULT; AGED; ARTICLE; CASE CONTROL STUDY; CONSULTATION; CONTROLLED STUDY; DEMENTIA; DEMOGRAPHY; DIABETES MELLITUS; DISEASE ASSOCIATION; FEMALE; HUMAN; INCIDENCE; INFECTION; INFLAMMATION; MAJOR CLINICAL STUDY; MALE; PATHOGENESIS; PRIORITY JOURNAL; RISK FACTOR; SEX DIFFERENCE; SMOKING HABIT;

AGED; AGED, 80 AND OVER; CASE-CONTROL STUDIES; COMMUNICABLE DISEASES; CONFIDENCE INTERVALS; DATABASES; DEMENTIA; FEMALE; HUMANS; LOGISTIC MODELS; MALE; MIDDLE AGED; ODDS RATIO; RETROSPECTIVE STUDIES;

EID: 23044447002     PISSN: 08930341     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.wad.0000165511.52746.1f     Document Type: Article

References (16)

1. Akiyama H, Barger S, Barnum S, et al. Inflammation and Alzheimer's disease. Neurobiol Aging. 2000;21:383-421.
2. Kawas C, Gray S, Brookmeyer R, et al. Age specific incidence rates of Alzheimer's disease: the Baltimore longitudinal study of aging. Neurology. 2000;54:2072-2077.
3. National Statistics. Living in Britain, 2001. Available at: www.statistics. gov.uk/lib2001/viewerchart5040.html. Accessed August 31, 2004.
4. Holmes C, El-Okl M, Williams AL, et al. Systemic infection, interleukin 1β and cognitive decline in Alzheimer's disease. J Neurol Neurosurg Psychiatry. 2003;74:788-789.
5. Nee L, Lippa C. Alzheimer's disease in 22 twin pairs-13 year follow-up: hormonal, infectious and traumatic factors. Dement Geriatr Cogn Disord. 1999;10:148-151.
6. Hofman A, Ott A, Breteler M, et al. Atherosclerosis, apolipoprotein E, and prevalence of dementia and Alzheimer's disease in the Rotterdam study. Lancet. 1997;349:151-154.
7. Almeida O, Hulse G, Lawrence D, et al. Smoking as a risk factor for Alzheimer's disease: contrasting evidence from a systematic review of case-control and cohort studies. Addiction. 2002;97:15-28.
8. Lindsay J, Laurin D, Verreault R, et al. Risk factors for Alzheimer's disease: a prospective analysis from the Canadian study of health and aging. Am J Epidemiol. 2002;156:445-453.
9. Knopman D, Boland LL, Mosley T, et al. Cardiovascular risk factors and cognitive decline in middle aged adults. Neurology. 2001;56:42-48.
10. Macknight C, Rockwood K, Awalt E, et al. Diabetes mellitus and the risk of dementia, Alzheimer's disease and vascular cognitive impairment in the Canadian Study of Health and Aging. Dement Geriatr Cogn Disord. 2002;14:77-83.
11. Van Duijn CM, Clayton D, Chandra V, et al. Familial aggregation of Alzheimer's disease and related disorders: a collaborative re-analysis of case-control studies. EURODEM risk factors research group. Int J Epidemiol. 1991;20(Suppl 2):s13-s20.
12. Kousman JP, Parret P, Dantzer R. Cytokine-induced sickness behaviour: mechanisms and implications. Trends Neurosci. 2002;25:154-159.
13. McGeer EG, McGeer PL. Brain inflammation in AD and the therapeutic implication. Curr Pharm Des. 1999;5:821-836.
14. Combrinck MI, Perry VH, Cunningham C. Peripheral infection provokes exaggerated sickness behaviour in pre-clinical murine prion disease. Neuroscience. 2002;112:7-11.
15. Buljevac D, Flach HZ, Hop WC, et al. Prospective study on the relationship between infections and multiple sclerosis. Brain. 2002;125:952-960.
16. int'Veld BA, Ruitenberg A, Hofman A, et al. Nonsteroidal anti-inflammatory drugs and the risk of Alzheimer's disease. N Engl J Med. 2001;345:1515-1521.